SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 46 filers reported holding SIGILON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $89,753 | +213597.6% | 96,499 | -21.4% | 0.00% | – |
| Q4 2022 | $42 | -99.9% | 122,799 | +0.3% | 0.00% | – |
| Q3 2022 | $61,000 | -39.0% | 122,379 | +0.9% | 0.00% | – |
| Q2 2022 | $100,000 | -72.5% | 121,245 | -50.9% | 0.00% | – |
| Q1 2022 | $363,000 | -43.8% | 247,177 | +5.6% | 0.00% | – |
| Q4 2021 | $646,000 | -50.6% | 234,153 | +1.1% | 0.00% | – |
| Q3 2021 | $1,308,000 | -8.9% | 231,662 | +73.2% | 0.00% | – |
| Q2 2021 | $1,435,000 | -47.3% | 133,775 | +9.7% | 0.00% | – |
| Q1 2021 | $2,725,000 | +235.2% | 121,940 | +620.3% | 0.00% | – |
| Q4 2020 | $813,000 | – | 16,929 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 740,740 | $35,578,000 | 13.90% |
| Flagship Pioneering Inc. | 10,370,369 | $498,089,000 | 9.07% |
| Monashee Investment Management LLC | 561,628 | $26,975,000 | 3.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 567,460 | $26,061,000 | 2.31% |
| Avidity Partners Management LP | 688,000 | $33,045,000 | 1.07% |
| SECTORAL ASSET MANAGEMENT INC | 225,000 | $10,807,000 | 0.76% |
| Artal Group S.A. | 276,000 | $13,256,000 | 0.28% |
| GILDER GAGNON HOWE & CO LLC | 662,227 | $31,807,000 | 0.16% |
| CANADA PENSION PLAN INVESTMENT BOARD | 1,485,185 | $71,333,000 | 0.11% |
| Perceptive Advisors | 125,000 | $6,004,000 | 0.06% |